Recursion CEO Chris Gibson on Accelerating the Biopharmaceutical Industry With AI - Ep. 230 1u3z2g

Techbio is a field combining data, technology and biology to enhance scientific processes — and...

Techbio is a field combining data, technology and biology to enhance scientific processes — and AI has the potential to supercharge the biopharmaceutical industry further. In this episode of NVIDIA’s AI Podcast, host Noah Kravitz speaks with Chris Gibson, cofounder and CEO of Recursion, about how the company uses AI and machine learning to accelerate drug discovery and development at scale. Tune in to hear Gibson discuss how AI is transforming the biopharmaceutical industry by increasing efficiency and lowering discovery costs.

Snowflake's Baris Gultekin on Unlocking the Value of Data With Large Language Models - Ep. 231 9 meses 32:10 Machina Labs’ Edward Mehr on Autonomous Blacksmith Bots and More 9 meses 37:25 SonicJobs CEO Mikhil Raja on Using AI Agents to Connect the Internet, starting with Jobs - Ep. 233 8 meses 27:33 NVIDIA's Josh Parker on How AI and Accelerated Computing Drive Sustainability - Ep. 234 8 meses 35:01 Zoom CTO Xuedong "XD" Huang on How AI Revolutionizes Productivity - Ep. 235 7 meses 36:35 Ver más en APP Comentarios del episodio 49502r